MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.91556

Медицинская библиотека · Cureus · 2025

Residual Eosinophilic Inflammation of Sinonasal Mucosa Under the Maintenance Phase of Eosinophilic Granulomatosis With Polyangiitis.

Ishikawa Masaaki, Nishisaka Kazuma, Inoue Mie, Ainai Shizuko, Kageyama Goichi

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Comorbid chronic rhinosinusitis (CRS) can be observed during the maintenance phase of eosinophilic granulomatosis with polyangiitis (EGPA), particularly during the tapering of oral corticosteroid (OCS) dosages, even when treated with mepolizumab (MPZ). Control of the comorbid CRS might be key for the remission of EGPA with lower OCS dosages, but the clinical features remain unclear. This study retrospectively investigated the clinical features of comorbid CRS during the EGPA maintenance phase.

METHODS

11 patients were included in this study. Clinical data, including details of the EGPA treatment, were analyzed. The histopathological eosinophilic count was assessed to determine the phenotype of the comorbid CRS. To assess the severity, the criteria defining primary eosinophilic CRS (eCRS) were used: a histopathological eosinophilic count ≥10 per high-power field.

RESULTS

The median SNOT-22 score (interquartile range [IQR]) was 23 (15-55), and six (55%) patients were classified into the moderate/severe category of SNOT-22 stratification. Nine (82%) patients had nasal polyps (NPs). Six (55%), seven (64%), six (55%), and two (18%) patients received inhaled corticosteroids, MPZ, immunosuppressants, and nasal corticosteroids, respectively. All patients received OCS, and the median value (IQR) was 4 (1-5) mg/day. In absolute eosinophil count (AEC) of blood tests, one patient (9%) exhibited blood eosinophilia (AEC ≥500/μL), and the median value (IQR) was 52 (29-371) /μL. In the histopathological eosinophilic count of the sinonasal mucosa, 10 (91%) patients met the diagnostic criteria for primary eCRS, with a median value (IQR) of 136 (78-134) cells/high-power field.

CONCLUSIONS

NPs with eosinophilic inflammation without blood eosinophilia can be observed during the maintenance phase of EGPA. Current treatments, including MPZ for EGPA and its comorbidities, may be insufficient to control comorbid CRS. Endotypic investigation of the sinonasal mucosa is required to elucidate its pathophysiology.

Для цитирования: Ishikawa Masaaki, Nishisaka Kazuma, Inoue Mie, Ainai Shizuko, Kageyama Goichi. Residual Eosinophilic Inflammation of Sinonasal Mucosa Under the Maintenance Phase of Eosinophilic Granulomatosis With Polyangiitis.. Cureus. 2025. DOI: 10.7759/cureus.91556.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.